Amanote Research
Register
Sign In
Fate of 35s-Cystine in Multiple Myeloma
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.1960.83
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
December 1, 1960
Authors
E Siegel
B A Sachs
F A Graig
Publisher
Springer Science and Business Media LLC
Related search
The Rate of Incorporation of [35S]methionine and [35S]cystine Into Proteolipids and Proteins of Rat Brain
Biochemical Journal
Mesangiogenic Progenitor Cells Are Forced Toward the Angiogenic Fate, in Multiple Myeloma
Oncotarget
Oncology
Metabolism of Cystine by Merino Sheep Genetically Different in Wool Production IV. Rates of Entry of Cystine Into Plasma, Measured With a Single Intravenous Injection of L- [35S] Cystine, and the Subsequent Incorporation of 35S Into Wool Fibres
Australian Journal of Biological Sciences
Multiple Myeloma
Annals of Internal Medicine
Internal Medicine
Medicine
Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Multiple Myeloma
Cancer Imaging
Nuclear Medicine
Radiology
Ultrasound Technology
Oncology
Radiological
Imaging
Medicine
Increased Expression of Cystine/Glutamate Antiporter in Multiple Sclerosis
Journal of Neuroinflammation
Molecular Neuroscience
Neurology
Immunology
Cellular
Neuroscience
Curability of Multiple Myeloma.
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Editorial: Immunotherapy in Multiple Myeloma
Frontiers in Immunology
Allergy
Immunology